Jubilant HollisterStier, a wholly-owned subsidiary of Jubilant Pharmova (NSE:JUBLPHARMA, BOM:530019), has launched a new high-speed isolator-based sterile fill and finish line at its Spokane manufacturing facility in the US, according to a Friday filing to the Indian bourses.
The company invested $132 million towards the new third line, which is part of its expansion plan for an additional 50% at the Spokane manufacturing facility.
The commissioning of its upcoming fourth Line, Jubilant HollisterStier, will help Jubilant HollisterStier to double its total sterile injectable manufacturing capacity at its Spokane unit.